Loading...
XNYS
LH
Market cap25bUSD
Oct 08, Last price  
314.20USD
1D
0.71%
1Q
13.51%
Jan 2017
184.88%
Name

Laboratory Corporation of America Holdings

Chart & performance

D1W1MN
XNYS:LH chart
P/E
29.39
P/S
1.85
EPS
10.69
Div yield, %
0.92%
Shrs. gr., 5y
-3.08%
Rev. gr., 5y
-0.04%
Revenues
13.95b
+7.25%
3,590,800,0004,068,200,0004,505,200,0004,694,700,0005,003,900,0005,542,300,0005,671,400,0005,808,300,0006,011,600,0008,680,100,0009,641,800,00010,441,400,00011,333,400,00011,554,800,00013,978,500,00013,136,100,00011,863,900,00012,161,600,00013,008,900,00013,951,700,000
Net income
877m
+17.49%
431,600,000476,800,000464,500,000543,300,000558,200,000519,700,000583,100,000573,800,000511,200,000436,900,000732,100,0001,268,200,000883,700,000823,800,0001,556,100,0002,377,300,0001,279,100,000418,000,000746,000,000876,500,000
CFO
1.64b
+3.45%
632,300,000709,700,000780,900,000862,400,000883,600,000855,600,000841,400,000818,700,000739,000,000982,400,0001,175,900,0001,459,400,0001,305,400,0001,444,700,0002,135,300,0003,109,600,0001,955,900,0001,327,700,0001,585,800,0001,640,500,000
Dividend
Aug 28, 20260.72 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Labcorp Holdings, Inc. delivers specialized diagnostic laboratory services. Its purpose is to empower a diverse group of stakeholders – including medical professionals, hospitals, pharmaceutical companies, scientific researchers, and individual patients – to arrive at well-informed and confident decisions. The organization commenced operations on April 16, 2024, and conducts its central management from its headquarters in Burlington, North Carolina.

Related entities

Subsidiaries (10)
CHILTERN INTERNATIONAL LIMITED
CLEARSTONE HOLDINGS (INTERNATIONAL) LTD
Dynacare Company
FORTREA DEVELOPMENT LIMITED
Labcorp Central Laboratory Services GmbH
LABCORP CLINICAL RESEARCH UNIT LIMITED
LABCORP EARLY DEVELOPMENT LABORATORIES LIMITED
Labcorp International Holdings B.V.
LABCORP INTERNATIONAL HOLDINGS LIMITED
COVANCE LIMITED

Key people

Adam Schechter
Chairman of the Board, President, Chief Executive Officer · since 2020
Glenn Eisenberg
Chief Financial Officer, Executive Vice President · since 2014
Thomas Pike
President, Chief Executive Officer - Clinical Development Business Unit · since 2023
Anita Graham
Chief Human Resources Officer, Executive Vice President · since 2023
Megan Bailey
Executive Vice President, Chief Strategy and Transformation Officer · since 2023
Brian Caveney
Executive Vice President, President, Early Development, Chief Medical and Scientific Officer · since 2023
Jonathan Divincenzo
Executive Vice President, President, Central Laboratories and International · since 2023
Mark Schroeder
Executive Vice President, President - Diagnostics Laboratories, Chief Operations Officer · since 2023
Peter Wilkinson
Senior Vice President, Chief Accounting Officer · since 2019
Lance Berberian
Executive Vice President, Chief Information and Technology Officer · since 2020
Amy Summy
Executive Vice President, Chief Marketing Officer · since 2020
Sandra van Der Vaart
Executive Vice President, Chief Legal Officer, Chief Compliance Officer, Corporate Secretary · since 2020
Kerrii Anderson
Independent Director · since 2006
Jeffrey Davis
Independent Director · since 2019
D. Gary Gilliland
Independent Director · since 2014
Kirsten Kliphouse
Independent Director · since 2022
Garheng Kong
Lead Independent Director · since 2023
Peter Neupert
Independent Director · since 2023
Richelle Parham
Independent Director · since 2016
Paul Rothman
Independent Director · since 2023
URL
https://www.labcorp.com/
IPO date
Apr 24, 1991
Employees
60,000
Domiciled in
US
Incorporated in
US
Legal address
251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808
US
Headquarters
2626 Glenwood Avenue, Suite 550
Raleigh, NC 27608
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT